Kemsa Strategic Plan
Kemsa Strategic Plan
CHAPTER 1: INTRODUCTION. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Background Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Situational Analysis: Operating Context . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.3 Rationale for developing the Strategic Plan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.4 Strategic Planning Process. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
I am delighted to present to you the KEMSA Strategic Plan 2019–2024 which outlines the vision
and the strategic direction that the Authority has identified to enable it realize its mandate.
The process of formulating this Strategic Plan has provided KEMSA the opportunity to
take stock of achievements and challenges, to determine the strategic direction in light of
opportunities and threats ahead.
The strategic pillars and objectives attest to our commitment to achieve excellence in our core
functions and mandate. We are committed to achieve excellence in procurement, warehousing,
and distribution of quality, affordable Health Products and Technologies (HPTs) to public
health facilities.
In implementing this strategic plan, KEMSA will make a significant contribution towards the
attainment of Universal Health Coverage (UHC). KEMSA’s role in the success of UHC is the
provision of quality, accessible and affordable HPTs.
Many thanks go to the Government of Kenya, through the Ministry of Health, for its continued
support in the development of this Strategic Plan. I wish to recognize the support accorded
to KEMSA by development partners and USAID in particular for the financial support in the
development of this strategic plan.
I would also like to take this opportunity to offer my sincere gratitude to all who have
contributed towards the formulation of this strategic plan. On behalf of the KEMSA Board
of Directors, I hereby call upon all stakeholders to continue with their support to see this
strategic plan to the end of its successful implementation.
This strategic plan was developed through the commitment and support of many individuals
and institutions. We would like to extend our sincere gratitude to USAID for their financial
support, which was necessary for the successful development of this strategic plan. We are
indebted to our customers at the National and County level who provided feedback on the
performance of KEMSA over the last five years. The feedback offered us ideas and insights
on the strategic direction that KEMSA should pursue between 2019 and 2024. We also ac-
knowledge the immense support received from the Ministry of Health, Council of Governors
(CoG), and the County Executive Committee Members (CECMs) for Health.
We are grateful to all our stakeholders including development partners who gave valuable
input into the strategic plan development process. Our special thanks go to the KEMSA
Board of Directors, management and staff for the insight and encouragement throughout the
process. We would like to give special thanks to the Consultants, Ansoffs Consulting Ltd
who guided development of this strategy.
Finally, we would like to recognize the invaluable support from KEMSA’s technical team
who were involved at all stages of developing the plan. To all of you who supported the
development of this strategic plan in a small or big way we say - “Thank You!”
Dr Jonah Manjari
Chief Executive Officer
Kenya Medical Supplies Authority
Health Products and Technologies distributors and wholesalers in Africa face a complex en-
vironment due to changing consumer demands, stringent government regulations, sub-stan-
dard products and counterfeit medicines. However, HPTs supply chain organizations are
considered a lifeline to the healthcare and life-saving industry since they are required to de-
liver quality products to the right facility at the right time. The changing consumer demands
may likely have an impact on performance of HPTs supply chain organizations and therefore
require strategic and operational responses by these organizations.
This Strategic Plan provides Kenya Medical Supplies Authority as an HPTs supply chain
organization, with a road map of direction towards the delivery of quality services to
the customers. The development of this strategic plan adopted a participatory approach
that ensured the involvement and consultations with the staff of Kenya Medical Supplies
Authority, stakeholders and members of the Board of Directors at different stages. The plan
outlines the vision, mission, core values, strategic objectives as well as targets and action
plan. The strategic plan has six chapters that include an Introduction; Strategic Direction,
Strategic Analysis, Environmental Scanning; Strategic Issues, Objectives and Strategies,
Strategic Implementation Framework and Strategy Control, Monitoring and Evaluation.
Vision Statement
A world class provider of health supply chain solutions that save and transform lives
Mission Statement
To provide reliable, affordable and quality health products, technologies, and supply chain
solutions for improved health care.
Core Values
1. Customer Focus
2. Diversity and Inclusivity
3. Innovation
4. Integrity
5. Professionalism
Strategic Objectives
The organization has identified several themes as a guide in its development. To address
these strategic themes, the organization has formulated a number of strategic objectives and
activities:
(i) To ensure a robust financial framework for concrete financial base
(ii) To increase market share from 70% to 90%.
(iii) To have robust physical facilities, internal business processes, systems and infrastrutural upgrades
that support business growth
(iv) To develop and strengthen strategic alliances and partnerships for improved health supply chain
systems
(v) To develop a dynamic, transparent and accountable governance structure
Budget
Implementation of the report is projected to cost a total of Ksh 20,734,400,000 over the five-
year plan period. Implementation will be within a framework of an Implementation Matrix
(IM) which gives a detailed list of activities deliberately selected to realize strategies that feed
into the key objectives. The IM also gives the Key Performance Indicators, the Output, The
annual targets and responsible office.
The plan further includes Annual Work Plans divided into quarters for the next five years
and an Enterprise Risk Management Matrix that gives an analysis of possible risks and
mitigations.
Indeed, Sustainable Development Goals No. 3 reads; Ensure healthy lives and promote wellbeing
for all at all ages thereby thrusting the prominence of citizen’s health to the forefront of respon-
sibilities for all governments.
As the government agency mandated to procure, warehouse and distribute HPTs to public
health facilities at both levels of government, KEMSA is in a unique position to deliver this
constitutional promise to the people of Kenya even as Kenya strives to meets its obligations
to the global community.
The health sector policy and strategic direction is guided by the Kenya Health Sector Strategic
and Investment Plan (KHSSP) 2013 – 2018 and the Kenya Health Policy 2014 – 2030. KHSSP
has set “better access to health services” and “improved quality of service delivery” as two desir-
able outputs and has identified the health workforce, infrastructure development and health
products as the critical inputs. Specifically, the Kenya Health Policy has set the following
objectives:
(i) Eliminate communicable diseases.
(ii) Reduce and reverse rising burden of NCDs.
(iii) Reduce the burden of violence and injuries.
(iv) Provide essential health care.
(v) Minimize exposure to health risk factors.
(vi) Strengthen collaboration with health related sectors.
The Kenya Health Policy further indicates in its policy framework that HPTs, the mainstay
of KEMSA’s mandate, is among the high priority policy investment areas (policy orientation)
which will operate to influence outcomes (policy objectives) (Figure 1). KEMSA, therefore,
will play a pivotal role in the health sector.
The above objectives have direct implications on KEMSA, as shown in Table 1 below.
Table 1: KHSSP Objectives and their implications on KEMSA
Objective Implication on KEMSA
KEMSA must supply the HPTs required to meet this
(i) Eliminate communicable diseases.
objective
(ii) Reduce, and reverse rising burden KEMSA must step in to supply the HPTs that may be
of NCDs. used to ease the effects of the NCDs
(iii) Reduce the burden of violence and KEMSA must be able to supply high quality first aid
injuries HPTs
KEMSA must supply the HPTs required to provide
(iv) Provide essential health care.
essential health care
The first change enabled KEMSA to expand its facilities and therefore enhance its operations.
The second change raised the profile of the Authority by granting it semi-autonomy status
from its earlier status of being an agency of the Ministry of Health. It also moved KEMSA
from a push system of supplying health facilities to a more responsive pull system.
In March 2019, the KEMSA Act was amended through the Health Laws (Amendment) Act,
No. 5 of 2019 to make the Authority the only point of call for procurement of HPTs by all pub-
lic health service providers. This amendment states that a national or county public health
facility shall, in the procurement and distribution of drugs and medical supplies, obtain all
such drugs and medical supplies from the Authority subject to: —
(a) the drug being duly registered by the Pharmacy and Poisons Board; and
(b) the drugs and medical supplies meeting the standards of quality and are efficacious as
authorized by the Pharmacy and Poisons Board.
The Government of Kenya (GOK) is committed to implementing Universal Health Coverage
(UHC), as one of her Big Four (4) Agenda, towards socio-economic development that ensures
all individuals and communities in Kenya have access to the quality essential health services
that they need without suffering financial hardship. To achieve UHC, HPTs must reach pa-
tients with their safety and quality guaranteed.
In the long run, UHC is expected to bring health and development efforts together and con-
tribute to poverty reduction as well as building solidarity and trust, aspirations that are also
enshrined in the government development blueprint – the Kenya Vision 2030. A UHC road-
map was developed to guide the implementation of the UHC agenda in the health sector and
the country at large. The pilot phase, being implemented in the year 2018/2019, targets Mach-
akos, Kisumu, Isiolo and Nyeri counties, with a view to draw lessons necessary for scaling it
up to cover the entire country. KEMSA is envisioned to provide a total solution to ensure that
there are no supply gaps during implementation of UHC for the entire country. This strategic
plan aligns strategies, key activities and timelines towards realization of UHC.
KEMSA supply chain activities encompass a range of functions, including product selection,
forecasting, quantification, procurement, warehousing, and distribution, among others. The
Kenya Medical Supplies Authority Act No. 20 of 2013 gives the Authority greater autonomy
Strategic Plan 2019 – 2024 3
to run its affairs and prescribes the following functions under Section 4 (1):
1. Procure, warehouse and distribute drugs and medical supplies for prescribed pub-
lic health programmes, the national strategic stock reserve, prescribed essential health
packages and national referral hospitals.
2. Establish a network of storage, packaging and distribution facilities for the provision of
drugs and medical supplies to health institutions.
3. Enter into partnership with or establish frameworks with county Governments for pur-
poses of providing services in procurement, warehousing, distribution of drugs and
medical supplies.
4. Collect information and provide regular reports to the national and county governments
on the status and cost-effectiveness of procurement, the distribution and value of pre-
scribed essential medical supplies delivered to health facilities, stock status and on any
other aspects of supply chain system status and performance which may be required by
stakeholders.
5. Support County government to establish and maintain appropriate supply chain system
for drugs and medical supplies.
The Health Laws (Amendment) Act, 2019 No. 5 of 2019 amended the KEMSA Act, 2013 by
introducing Sub-section (3) of Section 4 that states as follows:
“(3) A national or county public health facility shall, in the procurement and distribution of
drugs and medical supplies, obtain all such drugs and medical supplies from the Authority
subject to—
(a) the drug being duly registered by the Board (Pharmacy and Poisons Board); and
(b) the drugs and medical supplies meet the standards of quality and are efficacious as
authorized by the Board (Pharmacy and Poisons Board).
Kenya Medical Supplies Authority Act, 2013 and The Health Laws (Amendment) Act, 2019
serve to grant autonomy and to clarify that the role of KEMSA in the public HPTs supply
chain is significant and critical.
As the standard of living improves, healthcare providers face rising expectations for more
and better quality services. Increased access to information and technology has led to changes
in demand as more customers are using digital solutions to place orders and obtain product
information. Subsequently, for distributors and wholesalers of HPTs to gain a competitive
advantage in Africa, they need to have the ability to innovate and adapt to new regulatory
standards and the distribution requirements of products.
A leading health service provider needs to have efficient processes to deliver affordable and
quality treatment in a cost-effective way. The service provider also needs a deep understand-
ing of the industry and its trends so that the provider can advise its stakeholders, and identify
and collaborate with other strategic players to deliver better solutions to the patients. Addi-
tionally, medicines sold in Africa tend to have a number of quality issues, like ingredients
whose concentrations are either too high or too low, existence of impurities and poor quality
ingredients as well as incorrect labelling in some cases. The presence of these issues jeop-
ardizes the health of a population and, KEMSA is positioned to bridge this quality gap by
ensuring safety HPTs and specifically efficacy of medicines.
Figure 4: Strategic Planning Process: Continuous Monitoring and Evaluation Source: MoH 2018 -
KHHEUS
ii. No real increases in health expenditure: Government allocation for health is low, thus there
is need for additional mechanisms to increase domestic allocations. According to the
Ministry of Health, the highest combined (County and National Governments) expendi-
ture between was 7.8% in 2012/2013 the lowest was 5.5% in 2013/2014 (Figure 3). These
allocations to the health sector by both national and county governments were way be-
low the Abuja Declaration of at least 15% of government budgets being directed to the
health sector. This implies that on the overall, funding directed towards the health sector
was only about 50% of the Abuja Declaration.
iii. Funding landscape: Even though donor support to the health sector accounts for almost
one third of total current health expenditure, a significant proportion of the financing is
off-budget and targets few major diseases. It is also noted that donor support is declin-
ing in the country.
iv. There has been inefficient management of the multiple funding sources and dependence on donor
and out-of-pocket funding: The current health financing architecture is quite complicated,
with multiple sources of funding contributing to a meshwork of financing agents that are
purchasing services in multiple and overlapping manner.
v. High inequities in current pooling and management arrangements: Statistics from the Ken-
ya Household Health Expenditure and Utilization Survey as quoted in Kenya Health
Financing System Assessment, 2018 (MOH, 2018) revealed that households in the poor-
est wealth quintile predominantly sought healthcare from public health centers (51.4%)
compared to households in the richest quintiles (40%). This could be attributed to de-
liberate government policies to improve the access of the poor to primary healthcare in
public health facilities. Similarly, the dominance of wealthier or employed individuals
among private hospital users is largely due to the factors that facilitate access to private
care, especially access to medical insurance. In Kenya the government has greatly made
strides in correcting this by enabling the general population access to medical insurance
though NHIF.
vi. Reforms in the National Health Insurance Fund: From 2013, the National Health Insurance
Fund (NHIF) has undergone structural changes to make the institution more effective
and responsive to customer needs. In addition to structural changes the following chang-
es have also been instituted; -
(a) Reviewing contributions rates;
(b) Expanding the benefit package to include out-patient cover and new packages re-
lated to addressing non-communicable conditions;
(c) Instituting strategies to enroll more members; and
(d) Implementing the insurance subsidy programme among the poor and vulnerable
The 2017 Health Act, Kenya Health Policy (2014-2030) and norms and standards (e.g. HPTs,
HRH, and infrastructure) are offering overall guidance to the health sector in the delivery
of quality care. Counties have established their health service management structures.
Devolution has created an enabling environment for counties to employ more staff & HPTs
which will enhance the health worker population ratio especially in hard to reach areas.
The development and functioning of the LMIS and the use of WhatsApp to follow-up stock
levels have helped to monitor and improve visibility of available stocks. All these have
contributed to increased visibility of essential medicine and supplies at all service delivery
levels.
UHC is one of the Government’s Big Four Agenda and, to achieve it, the security of Health
Products and Technologies is critical because no services can be rendered without the
necessary HPTs. Security of HPTs will require effective and efficient public health supply
chain that can deliver quality HPTs in a reliable and cost-effective way. An increased scope of
commodities is also necessary to support the reviewed KEPH which focuses on responsiveness
to the population needs especially expanding primary care services. Such services include
screening laboratory commodities, as well as coverage for more non-communicable diseases.
In addition, price reduction strategies, prudent commodity management and rational use
will play a greater role in ensuring access to HPTs.
The ending strategic plan (2014-2019) paves way for another five-year Strategic Plan that will
guide the Authority’s operations from 1st July 2019 to 30th June 2024. The Strategic Plan is
aimed at aligning KEMSA with the devolved system of government in light of the country’s
health sector context and the imminent roll out of the UHC. The overall goal is to ensure that
public health facilities optimally receive adequate health products and technologies. KEMSA
has to re-configure its business model by putting systems and structures in place to ensure
it had the requisite capacity and versatility to operate in a vastly different consignment
distribution model. The role of KEMSA’s national and regional depots is to ensure availability
of reliable, quality, and affordable health products & Technologies as per the national essential
commodities lists for pooling by the counties and public health facilities and institutions.
The rationale for this document includes, but not limited to, helping KEMSA to:
- Build stronger relationships with county governments and the wide variety of stakeholders through
participatory engagement.
- Have a strategic direction with a clear road map.
- Build teamwork, cohesion, and expertise amongst its staff.
- Bring coherence to different parts of the organization, ensuring that the operations of KEMSA are
pulling in the same direction.
- Mobilize and prioritize resources to achieve the Authority’s mission.
- Have sustainable growth and increase stakeholders’ value for money.
- Have firm presence and guarantee competitiveness in the market.
- Ensure stakeholders know where KEMSA wants to be in the next 5 years.
- Create a responsive and commercial culture throughout the organization.
In order to achieve these objectives, a robust interactive methodology was used with set
milestones to be achieved against corresponding timelines. This was made possible through
analyzing and understanding of the mandate, functions, and policies of KEMSA; analyzing
the current organizational structure in order to give a snapshot of how KEMSA departments
interface. In conducting this assignment, the consultant used systems thinking approach to
planning which has been proven to deliver results in sustainable ways. The approach raised
key systems thinking questions like; Where are we today? Where do we want to be? How do
we get where we want to be? How will we know when we get there? What will/may change
in the environment during our journey of getting where we want to be? What risks do we
foresee? For the identification of the Authority’s priority areas and to determine its strategic
objectives, some steps were followed, as summarized below.
(a) The first step of the strategic planning process was to conduct desk review and to collect
information from key stakeholders. Data collection tools (questionnaires and interview
guides) were developed and used to thoroughly review various aspects of KEMSA as an
organization. This step helped in creating the vision and mission statements as well as
core values. This phase of the process allowed KEMSA Board and Management to clarify
what the Authority is trying to achieve (vision) and articulate why it exists (mission).
Throughout the planning processes, the context within which KEMSA operates and how
the future is likely to unfold under the changing environment were taken into consider-
ation.
(b) The second step involved environmental scanning and intensive strategic analysis,
touching on political, economic, socio-cultural, technological, ecological and legal (PES-
TEL) factors. It also included identification of strengths, weaknesses, opportunities and
threats (SWOT), and both internal and external stakeholder analysis. Careful stakeholder
mapping was undertaken to determine the stakeholders’ roles in the strategic planning
process for early buy-in and successful implementation. This was an intensive exercise
which identified the key areas of KEMSA operations that may need targeted resources
as well as opportunities or opposing environmental factors that could affect strategy
implementation.
(c) The third step focused on strategic gap analysis to answer the question: “Where are we
compared to where we want to be?” This part of the process looked at KEMSA vision
which was guided by the analysis of where the Authority wants to be by June 2024, com-
paring this with where the Authority currently is. The analysis was done in light of the
strategic issues evident in KEMSA. All areas were identified and targeted for strategy
through the gap analysis process. The fourth step was grouping the strategic issues into
thematic areas and developing both strategic objectives and corresponding strategies.
The planning process adopted offers KEMSA an opportunity for periodic reviews.
Strategic Plan 2019 – 2024 9
This Strategic Plan is expected to be inspirational and valuable to all KEMSA stakeholders.
Strategy implementation process is continuous and adopts constant monitoring and taking
corrective actions. In addition, as KEMSA grows and changes, so will the various strategies.
Existing strategic issues will change and new ones will emerge during the plan period. Figure
4 constitutes part of the continuous process of improving the Authority’s operations in an
effort to attain and exceed organizational strategic objectives and strategies.
In the 2014-2019 Strategic Plan, KEMSA had identified four strategic outcomes as the critical
success factors in achieving its corporate mission. They incorporate all of KEMSA’s opera-
tions, from supply chain to financial management and human resources. The Plan comprised
strategic objectives are logically organized and aligned with these four strategic outcomes as
summarized below:
Overall Goal: Expand market share, enhance customer satisfaction and strengthen KEMSA’s
financial performance and sustainability
Outcome 1.0: Demand for KEMSA commodities and services increased
SO 1.1: Develop and strengthen strategic alliances and partnerships
SO 1.2: Increase market share in existing markets
SO 1.3: Develop new markets for existing products
SO 1.4: Broaden product range
SO 1.5: Enhance commercial performance
SO 1.6: Improve marketing communication
SO 1.7: Strengthen the supply chain management capacity for county and facilities
SO 1.8: Improve customer retention
SO 1.9: Reposition SSD as an SBU and build its capacity
SO 1.10: Strengthen debt management
Outcome 4: KEMSA has in place a dynamic, efficient and sustainable institutional gover-
nance and management system
SO 4.1: Enhance KEMSA governance
SO 4.2: Enhance KEMSA human capital management
SO 4.3: Enhance KEMSA capitalization and financial management
SO 4.4: Strengthen enterprise risk management
SO 4.5: Develop capital and operational infrastructure to support KEMSA business
SO 4.6: Support KEMSA management systems, processes via automation and innova-
tion
SO 4.7: Strengthen corporate security management
The Health Laws (Amendment) Act, No. 5 of 2019 amended the 2013 Act to provide
for collaboration between the KEMSA and County Governments. The Health Laws
(Amendment) Act further provides that national and county health facilities would refer to
KEMSA for their drug and medical supplies needs.
2.2 Vision
KEMSA intends to continue pursuing its current dream of “being a leader in innovative health
supply chain solutions that support better health service delivery”. The revised vision of the
Authority is :
This statement of purpose expresses Authority’s reason for existence. The statement herein
below sets out KEMSA mission:
In pursuit of its vision and mission, KEMSA is guided by a set of core values that are shared and
practiced by its entire staff with a view to ensuring relevance and boosting motivation of all the
stakeholders
Organizations that do not adequately adjust to meet their environmental challenges easily
experience problems posed by environmental changes. The need to chart out a path for the
future requires a critical evaluation of the key factors, both internal and external, that will
impact on the operations of the organization. Strategic analysis and environmental scanning
is critical in the strategic planning process as it clarifies the context within which an organi-
zation operates. This analysis was achieved through the process of identifying the organiza-
tion’s strengths, weaknesses, opportunities and threats (SWOT).
The SWOT analysis discussed in this chapter is presented under the following sub-head-
ings; best practice in pharmaceutical supply chain; internal analysis, external analysis and
stakeholder analysis. While the external and competitive environments have implications for
the organization in the form of opportunities and threats, the internal environment anchors
the organization’s strengths and weaknesses. The external environment comprises of devel-
opments in both the organization’s macro (remote) environment and the micro (immediate
operating) environment. The competitive environment describes the industry dynamics in
which the organization is competing.
Effective health supply chain management involves the procurement of raw materials,
conversion of these materials into finished products, inventory management, and the
distribution of those products. Like for any other industry, the effective supply-chain
management is particularly important for the pharmaceutical industry. The industry must
seek ways to reduce costs and maintain regulatory compliance and quality and safety
standards in addition to normal supply chain challenges.
The goal of the Kenya Health Policy 2012-2030 is to attain the highest possible standard of health
in a responsive manner. The overall objective the same Health Policy is to attain universal
coverage of critical services that positively contribute to the realization of the policy goal. The overall
objective of Kenya Health Policy 2012-2030 is in tandem with the third goal of the Sustainable
Development Goals which seeks to Ensure healthy lives and promote wellbeing for all at all ages.
The goal and overall objective of the Kenya Health Policy 2012-2030 therefore thrusts KEMSA
right into the centre of the Ministry’s efforts to realize the health sector policy.
The following common gaps are relevant to health supply chain organizations: -
(i) Global quality standards –possible counterfeit and substandard products from the chain
(ii) Inventory management
The effectiveness of KEMSA strategy depends mainly on the identified strategic issues.
Sustainable competitive advantage requires capabilities that provide enduring benefits
and are not easily copied by competitors. The health supply chain sector players should
benchmark their performance against other sectors and adopt similar best practices for
improved performance.
It is important to mention that health supply chain decisions are subject to considerable risks.
Health supply chain and its effective utilization under uncertain and dynamic environment,
is a major challenge for the HPTs sector. For KEMSA to successfully protect itself against
these risks, proactive supply chain security must deliver actionable intelligence to mitigate
those risks. In pharmaceuticals, the most serious consequences of risks are those that affect
patient safety. Adverse patient reactions can range from minor to as severe as death. Other
consequences include drug recalls, and stolen drugs can compromise accuracy of volumes of
the actual drugs consumed. In general, KEMSA operations can incur daunting costs, such as
revenue loss, recall costs, legal costs for damage to health or life and regulatory fines.
According to the National and County Health Budget Analysis FY 2016/17 by the Ministry
of Health, the total National Government budget allocation to health, has been an average of
3.87% over the three-year period between 2014/2015 and 2016/2017. During the same period
the total County Government budget allocation to the same sector has been an average of
23.37%. The average budget allocation, that is, the proportion of the combined discretionary
public budget allocated to health by national and county governments during FY 2016/17
was 7.6%. This was below the pre-devolution level of 7.8 percent and way below the Abuja
declaration target of 15% (Figure 2 under Situational Analysis: Operating Context).
23
- Maintaining integrity & good governance
24
KEMSA’s engagement strategy for removing obstacles
Stakeholder Stakeholder interest (s) and concerns (What do they want?)
and obtaining support from the stakeholder
7. National Referral - Efficient distribution of medical supplies - Regular reports on stock levels and pricing.
Hospitals Entice them to buy our commodities
- Availability of stocks
- Affordability of medical supplies - More interactions, facility tours & sensitizations
25
- Efficient implementation of KEMSA’s programmes
Table 12: Stakeholder Mapping and Analysis: Internal Stakeholders
26
Stakeholder interest (s) and concerns (What do they KEMSA’s engagement strategy for removing obstacles
Stakeholder
want?) and obtaining support from the stakeholder
- Increased revenue generation - Regular reports from management
- Efficiency in the implementation of the strategic plan - Timely and well written board papers
- Adherence to policy and regulations - Constant engagement and information sharing by
KEMSA Board - Prudent use of finances management
- Staff discipline
- Overall excellent performance of the Authority
- Shorter turnaround times of approvals by the Board - Constant engagement with the Board
- Regular policy guidance by the Board - Regular stakeholder consultation forums
- Employees to adhere to policies and regulations - Establish a listening mechanism to obtain regular input
- Team efficiency in the implementation of work plans from employees
27
- Opportunities for career growth
- Fair administrative action
CHAPTER 4: STRATEGIC ISSUES, OBJECTIVES AND STRATEGIES
This part of the Strategic Plan identifies Strategic Issues that KEMSA has to address in order
to realize and experience its vision and mission respectively.
The KHSSP 2018 – 2030 has the following Key Outputs for Health Products and Technologies.
These issues have been analysed and appropriate actions recommended for KEMSA to take; -
1. Increased capacity and access to all health commodities
2. Enhanced quality of all health commodities
3. Prudent management of health commodities.
4. Enhanced support supervision for health commodities
1. Financial Stewardship
Financial stewardship is the pillar that represents the care, planning, attention, and manage-
ment of the organizational financial resources and choices.
Strategic Objective 1: To ensure a robust financial framework for concrete financial base.
Strategies:
1. Increase demand for KEMSA products.
2. Venture into new markets.
3. Increase revenue from supply chain services.
4. Share health supply chain expertise.
5. Enhance KEMSA capitalization from KES 8 Billion to KES 10 Billion.
Strategies:
1. Provide effective oversight
2. Strengthen management systems for enhanced efficiency
3. Improve public opinion, attitude and behavior of key stakeholders
4. Strengthen Enterprise Risk Management and Strengthen BCM
5. Strengthen corporate security risk and disaster management programmes
6. Review Human Capital Management Systems
7. Provide assurance on internal controls, governance and risk management systems
8. Ensure sustainability reporting
KEMSA’s pursuit of its vision and attainment of its mission is hinged on successful
implementation of this plan. The strategies identified herein were prioritized based on the
magnitude of the underlying issues.
34
Pillar 1: Financial Perspective
Strategic Objective 1: Ensure a robust financial framework for concrete financial base
Target/Time frame (by Plan Year)
By
Strategy Activity KPI Expected Output
Total-Plan Whom
1 2 3 4 5
Target
Increased No. of Fa-
Venture into new Implement Market No. of New market
cilities in New Mar- 20 20 20 20 20 100 DCS
markets. segmentation Segments on Board
kets from 200 to 300
No. of viable Partner- No. of viable Partner- DCS/
1 1 1 3
Develop and sustain ships ships from 7 to 10X DFS/MCP
viable Strategic part- Increase sales of DCS/
nerships. Values of supply
Increase revenue supply chain services 100M 100M 100M 100M 100M 500M DFS/
chain services
from supply chain from 1.5B to 2B CEO/DLS
services Develop and Review
a costing Policy for 100% Cost Policy Full compliance with
50 100 100 100 DFS
Management of Stra- Implemented Cost policy
tegic Partnerships
Establish a Health
No. of Supply Chain Supply Chain Insti-
supply chain institute 1 1 DFS
Institute established tute established
of excellence-
Engage the Chartered
Share Health Supply Institute of Supply
Chain Expertise. Chain Management
Accreditation ob-
(CISCM) and Kenya Accreditation Certif-
tained from KISM or 1 DFS
Institute of Supply icate
CISM or both
Chain Management
(KISM) for accredita-
tion
Lobby with GOK/
Enhance KEMSA
MOH and Develop- Value of KEMSA Increase of Capital-
Capitalization from 1B 1B 2B DFS
ment partners to fund Capital ization
KES 8B to 10B
capital expenditure
35
36
Pillar 2: Customer Focus
Strategic Objective 2: To increase Market Share from 70% to 90%.
Target/Time frame (by Plan Year)
To-
By
Strategy Activity KPI Output
1 2 3 4 5 tal-Plan Whom
Target
Improved compli-
Develop the Capaci- No. of Trainings con- ance with Policies,
ty of KEMSA staff on ducted procedures, regu- 200 200 200 200 200 1000 HRM
product knowledge No. of Staff Trained lations and to the
best practices
Increased aware-
Carry out focused mar- No of campaigns
ness of KEMSA 27 27 27 27 27 135 PRCM
keting promotions conducted
products
Increased under-
No. of Market Price
Conduct Market Price standing of the
Evaluations Conduct- 1 1 1 3 DCS
Research and surveys market & respond
ed
to it appropriately
37
38
Pillar 2: Customer Focus
Strategic Objective 2: To increase Market Share from 70% to 90%.
Target/Time frame (by Plan Year)
To-
By
Strategy Activity KPI Output
1 2 3 4 5 tal-Plan Whom
Target
Develop and execute
No. of CSR cam- Improved corpo-
corporate social respon- 4 4 4 4 4 20 PRCM
paigns rate image
sibility campaigns
Participate in relevant No. of Exhibitions &
Improved corpo-
healthcare exhibitions Trade fairs partici- 10 10 10 10 10 50 PRCM
rate image
and trade fairs pated
increased under-
No. of Media Engage- standing of the
Media Engagements 12 12 12 12 12 60 PRCM
ments KEMSA business
mandate
Improve marketing Publish quarterly
communication Increased knowl-
newsletter to deliver a
No. of Publications edge of KEMSA 4 4 4 4 4 20 PRCM
range of promotional
business
messages
Carry out media
engagement training Increased knowl-
No. of Key staff
for Key staff in sales, edge on media 100 100 PRCM
trained
customer service and management
technical staff
Involvement in relevant No. of conferences Increased product SSM/
professional confer- and seminars attend- knowledge and 4 4 4 4 4 HSSD/
ences & seminars ed market intelligence PRCM
Capacity Development 1. No. of Trainings
Improved manage-
on HPTs and data conducted
ment of HPTs at 6 6 6 6 6 DCS/BDC
management to KEMSA 2. No. of Health
facility level
customers Workers Trained
Improve customer rela- Complaints response
100% 100% 100% 100% 100%
tionship management Strengthen customer rate and % resolved Customer satisfac- 100%
and and and and and CSM
feedback Management on tine tion and 90%
90% 90% 90% 90% 90%
39
2. Improved OFR
40
Pillar 3: Internal Processes & Systems
Strategic Objective 3: To have robust internal processes and systems that support the business
Target/Time frame (by Plan Year)
Strategy Activity KPI Output Total-Plan By Whom
1 2 3 4 5
Target
Develop and update New product Specifi-
cations Developed Percentage HPTs
appropriate products &
with updated New and updated
specifications In collab- Existing products 230 230 180 130 130 900 QAM
product specifica- product specifications
oration with MOH & Specifications Re- tions
Customers viewed
No. Counties 1. Accurate consump-
Develop And Imple- Develop And Imple-
(47) and Referral tion data report ICTM/
ment Facility HPTs ment Facility HPTs 23 30 53
hospitals (6) using SMM
Consumption System Consumption System 2. Improved OFR
system (Total 53)
Develop an automat- Procure an Automat- A functional Auto-
Improved Forecast for ICTM &
ed HPTs forecasting ed HPTs forecasting mated forecasting 1 1
HPTs PCIM
system System System
Develop capacity of
counties Health work- Roll out training on
No. of counties Accurate HPTs data ICTM/
ers on the use of HPTs the use of HPTs data 12 12 12 11 47
trained management SMM
data management management system
system
Develop and Imple-
PD/
ment supplier perfor- Percentage ap- Performing and Re-
Appraise suppliers 20% 40% 40% 100% QAM/
mance measurement praised Suppliers sponsive suppliers
ICTM
system
Advocacy for the Re- Advocacy for the
Reviewed Act and Reviewed Act and
view of PPAD Act 2015 review of PPAD Act CEO/PD/
operationalized operationalized Reg- 1 1 2
and Operationalization and operationalize DCS
Regulations ulations
of Regulations regulations
Construct or refurbish
Establish a Microbiolo- A functional Micro- A functional Micro-
functional Micro-Biol- 0 0 1 0 0 1 QAM
gy Testing Laboratory Biology Lab Biology Lab
ogy Lab
Transition to and main- Maintain ISO17025:2017 1
tain ISO 17025:2017 ISO17025:2017 Ac- Accreditation Reliable Lab results 1 1 1 1 6 QAM
Accreditation creditation certificate certificate 1
Conduct ISO 9001:2015
Conduct ISO ISO 9001:2015 Au- KEMSA QMS
audits and Management 1 1 1 1 1 5 QAM
9001:2015 Audits dit status reports compliant
reviews
41
42
Pillar 3: Internal Processes & Systems
Strategic Objective 3: To have robust internal processes and systems that support the business
Target/Time frame (by Plan Year)
Strategy Activity KPI Output Total-Plan By Whom
1 2 3 4 5
Target
Improved efficiency
Percentage uti-
Review and improve Acquire internal dis- and effectiveness
lized of internal OD/DM/
internal distribution tribution fleet where of inter-warehouse 6 3 9
fleet for distribu- DHRA
fleet management necessary transfers and order
tion
deliveries
Percentage in-
Improve KEMSA stor- Increase the available crease in Ware- Increased storage space OD/
age space capacity for storage space capacity house Space and reduced operational 2 1 1 4 DHRA/
HPTs for HPTs Capacity cost. QAM
43
alize water treatment the water treat- Improved hygiene 1 1 DHRA
staff
plant ment plant
44
Pillar 4: Strategic Partnerships
Strategic Objective 4: To develop and strengthen strategic alliances and partnerships for improved health supply chain systems
45
46
Pillar 5: Leadership and Governance
Strategic Objective 5: To develop a dynamic, transparent and accountable governance structure and systems
Target/Time frame (by Plan Year)
Strategy Activity KPI Output Total-Plan By Whom
1 2 3 4 5
Target
47
48
Pillar 5: Leadership and Governance
Strategic Objective 5: To develop a dynamic, transparent and accountable governance structure and systems
Target/Time frame (by Plan Year)
Strategy Activity KPI Output Total-Plan By Whom
1 2 3 4 5
Target
Percentage of Compli- CEO/
Review and oversee im- Annual Training Plan 1 1 1 1 1 5 DHRA
ance to training plan
plementation of learn-
Percentage of success- Improved work out- CEO/
Strengthen corporate se- ing and development fully executed training puts and employee 85% 85% 85% 85% 85% 85% DHRA
curity risks and disaster programs programs performance
management programs
1 1 1 1 1 5 CEO/
Review effective Hu- Oversee Implementation 1. Approved annual DHRA
Employee Retention
man Capital Manage- of performance apprais- performance targets
Rate
ment Systems al system 2. Appraisal reports
70% 70% 70% 70% 70% 70%
No. Directorates & CEO/
Approved Succession
Implement Succession Departments with suc- 5 5 DHRA
Management plan
Management Plan cession management
plans CEO/
Succession plan reports 2 2 2 2 2 10 DHRA
Provide assurance on
Carry out external quali-
internal controls, gover- Quality assessment
ty assessment of internal Assessment Score 1 1 IA&RM
nance and risk manage- report
audit Department
ment systems
Successful strategy execution depends greatly on good internal environment and competent
personnel. A strategy implementer can opt for an active, visible role or a low-key,
behind the scenes role, remaining aloof from the day-to-day problems. To some extent,
therefore, each strategy implementation is unique enough to push for change in shaping
the character of implementation and moving the process along. Strategy implementers’
challenge in performing these tasks is to bring the Authority’s internal operations into good
alignment with strategy and to unite the total institution behind strategy accomplishment.
Strategy-supportive matches are needed with necessary skills and capabilities, area
activities, structures, incentives, policies and procedures, information systems and control
mechanisms, budgets and programmes, and shared values and norms. The Board’s role in
the implementation process is leading and setting the tone, the pace and style of strategy
implementation.
The structure, culture, policies, staff and leadership style will be driven towards successful
implementation of this strategic plan. Where there are inconsistencies, internal adjustment
will be necessary. The success of implementing the planned strategies would eventually lead
to improved overall performance and sustainable growth. KEMSA will continuously pursue
this Strategic Plan as a roadmap for sustainability and success. The Authority will ensure ef-
fective institutionalization and operationalization during strategy implementation.
The Kenya Health Sector Partnership and Coordination Framework 2018-2030 establishes
structures and mechanisms that bring together all key partners in the health sector at different
levels to work in collaboration to achieve priority sector objectives and results. To improve
the overall partnership and coordination in KEMSA, the following issues will be prioritized:
improving operationalization of agreed coordination structures; strengthening harmoniza-
tion efforts amongst stakeholders; establishing a capacity building process for partnerships;
and establishing a fully functional partnership mechanism. For effective implementation ar-
rangement, a common planning and annual budgeting process will be adopted. The common
planning framework will be defined by the Kenya Health Policy 2014-2030, the Kenya Health
Sector Strategic and Investment Plans (KHSSPs) Annual Work Plans, County Integrated De-
velopment Plans (CIDPs) and National Programme Plans.
There is need to communicate this strategy deliberately in order to attain, strengthen and
preserve a favorable opinion of the Strategic Plan and to ensure buy-in from all relevant part-
Strategic Plan 2019 – 2024 49
ners and stakeholders. The communication will focus on: ensuring that all stakeholders are
fully informed and understand their roles and responsibilities in implementation of the SP,
enhancing consultation with agencies in achieving set outcomes and ensuring that all stake-
holders understand the SP and ongoing reform process.
The five-year Strategic Plan (2019-2023) calls for Annual Operational Plans (AOPs), meaning
that during each year, the various departments will pick out strategies and activities planned
for that particular year and schedule them accordingly. This will be done through assigning
tasks and responsibility to the implementers as well as budgeting. Annual Work Plans will
be completed before developing the budgets. To implement the Plan, the Authority will need
to carry out annual budgeting to ensure resources mobilization and determine the estimated
amount of resources required each year. The budgetary requirements and projections will be
developed and approved by the Board of Directors annually in form of an operational annual
budget. Annual action plans will be extracted by the parties responsible for implementation.
These annual operational plans will then be synchronized with the planned strategic
deliverables. Annex 2 outlines KEMSA Annual Work Plans.
Attracting, maintaining and retaining qualified and competent human capital is one of
the key drivers of successful strategy implementation. Short-term and long-term staff
development programmes should form part of the human resource management that supports
implementation of the planned activities to attain the set goals and objectives. Successful
implementation of the Strategic Plan is therefore, dependent on the Authority’s human
capital management. To reduce undue bureaucracy and enhance efficiency, the following
will be necessary:
(i) Once the annual budget is duly drawn up and approved by the Board, the responsibility of imple-
mentation is decentralized to departments.
(ii) The governance structures should be streamlined to ensure smooth operation of each department.
51
52
Strategic Cost of Implementation in Million KES
No. Pillar Strategies
objectives Year 1 Year 2 Year 3 Year 4 Year 5 Total
4 Strategic Part- 1. Develop and sustain transformational 41.94 33.34 37.04 33.39 34.92 180.6
nership To develop relationships with development partners.
and strengthen
alliances and 2. Leverage on the strength of local manu-
partnerships facturers and industry players.
for improved 3 Build and sustain partnerships with key
health supply stakeholders
chain systems
5 Leadership and To develop 1. Strengthen management systems for 377.5 1349.5 380.875 332.5 329.5 2,769.9
Governance a dynamic, enhanced efficiency
transparent 2. Strengthen public opinion, attitude and
and ac- behavior of key stakeholders
countable
governance 3. To Strengthen ERM
structure and
4. Develop effective Human Capital Man-
systems
agement Systems
5. Provide assurance on internal controls,
governance and risk management systems
KEMSA will require about KSh. 20,734,400,000 (Approx.) to implement its activities over the plan period. The areas for which the funds
will be required and the estimated amounts are as given in the Implementation Matrix.
It is important to identify risks that would hinder strategy execution or reduce the positive
effect of this plan to allow for their mitigation. Potential risk factors and events which, if
they occurred, would threaten attainment of planned strategic objectives that were identified
These are risks that are not easily quantifiable but can be handled by widening of the resource
base and deflection of some activities during implementation. On a continuous basis, depart-
ments are expected to identify and profile potential operational risks to facilitate documen-
tation of the lessons learned. To mitigate these risk factors, KEMSA will develop a practical
Business Continuity Plan so that in the event of a disaster or disruption of the office facilities/
activities, the operations should resume within the shortest period possible based on the
backed-up data in a different location.
In order to achieve the Plan priority areas, there is recognition that key risks are likely to
affect the progress. The sources of risk are predicted in five related areas, which include
political commitment, political and social responsibility, inadequate financial resources, ep-
idemics, community involvement, provision of essential health care services, and quality of
care. KEMSA will ensure a “proactive approach” to ERM by beginning the risk management
activities early, making risk management iterative throughout the operations, ensuring solid
risk management processes, engaging risk owners early, training a team on risk management
processes, providing for multiple forms of risk identification activities, providing feedback
to risk owners and encourage frequent risk discussions. The actions will in turn ensure risk
management aligns with other primary constraints – scope, time, cost and quality.
One of the key elements of strategic planning is understanding why some organizations,
in the same context and with a well-documented Strategic Plan, succeed while others fail.
Strategy control links elements of strategic management and helps an organization to contin-
uously adjust or revise its strategic inputs and actions to achieve the desired goals/outcomes.
These elements provide indicators for strategy control through continuous monitoring and
periodic evaluation. Strategy monitoring, and evaluation involves examining how the strate-
gy is being implemented as well as the outcomes of the strategy. The implementation of this
plan takes into account that the country is under a devolved system of governance. Stake-
holders in the health sector will include state actors (National and County Governments),
health-related sectors, external actors (development partners), non-state actors (implement-
ing partners, private sector) and clients. Chapter 6 highlights how KEMSA ensures its strategy
monitoring and evaluation.
The 2019-2024 Strategic Plan has been designed to facilitate the realization of KEMSA vision
and mission and support accountability in the delivery of the Authority’s mandate. Since
monitoring and evaluation is a critical part of the service delivery process, the strategic plan
is cascaded to more sharply defined individual performance targets. The CEO will period-
ically monitor progress on the plans to provide briefing for the Board of Directors. In addi-
tion, regular meetings with departments/divisions will assess progress, resolve problems
and identify any support or development needs.
The success of the Strategic Plan significantly depends on how effectively the planned activities and
outputs are monitored and evaluated with a view to ensuring that KEMSA’s development over the plan
period (2019-2024) remains on the defined road map. Monitoring and evaluation framework, which
works in tandem with the Implementation Matrix, is designed to ensure the following:
(i) Establishment of an effective information system.
(ii) Establishment of clear reporting schedules, channels, and feedback mechanisms on an on-going
Quarterly and annual reports will be prepared and a comprehensive analytical report giv-
ing a snapshot of performance covering the different strategic objectives articulated in the
Strategic Plan (2019-2024) will be produced. A mid-term review and an end evaluation will
be undertaken to determine the extent to which the objectives of this Strategic Plan are met
across the different indicator domains. The principle of joint assessment will be used at all
levels during performance reviews. This will involve all stakeholders, both government and
non-government actors, in review of performance. The purpose of the joint assessment is to
review performance, determine priorities, action plans and spending for the subsequent pe-
riod. KEMSA CEO in conjunction with KEMSA Management, will be responsible for the day
to day implementation and coordination of the monitoring and evaluation this Strategic Plan.
At the beginning of each year, all the units (directorates and departments) will set their
performance targets as part of their Annual Work Plans as derived from their strategic activities.
In setting these targets, the performance should be monitored in a Special Management Meeting
planned and chaired by the CEO. The milestones of strategy monitoring, and reporting will
be done through bi-annual departmental work-plan implementation (monitoring) report.
Monitoring will help KEMSA to:
(i) Establish if performance targets have been met and deviations explained;
(ii) Act as an early warning sign and detect potential difficulties as well as help to address them during
implementation; and
(iii) Provide feedback to the next phase of implementation, reduce the cost and/or increase the efficien-
cy of post evaluation studies.
Timeline Output
Strategy Activities
Planned Actual Status Expected Actual Status
Progress Reports
Progress Reports, based on the above monitoring tool, will be prepared by all departments based on the
strategic objectives driven by the departments. The reports will be submitted to the PCI dept. Reports
will be prepared quarterly and annually. The annual reports will coincide with the KEMSA’s budgetary
cycles. Reports will be based on the quarterly work plans drawn from the Implementation Matrix and
will describe actions taken by departments toward achieving specific outcomes and strategies of the
plan and may include costs, benefits, performance measures and progress to date.
Evaluation will be undertaken by the PCI department in conjunction with the departmental Performance
Management champions and Heads of Departments. The PCI team will evaluate all strategies, activities
and outputs/outcomes with a view to advising the management on any performance gaps as well as
offering feasible strategy alternatives. The evaluation will entail the following:
6.4 Conclusion
Monitoring, evaluation and learning (MEAL) provide continuous feedback for plan review
and enhances constant communication, resulting in strategy modification. KEMSA has set
out a goal to improve its performance and to obtain a commitment from stakeholders to work
together towards these goals. Realistic expectations will be established to guide the journey
into the next five years.
The Authority will keep a vigilant eye over existing and emerging competition in order to
assure itself of growth and success in the pharmaceutical industry. Guided by this Strate-
gic Plan, KEMSA will strive to cultivate creativity in service delivery minimize stock outs,
ensure improved order fill rates, improved turnaround and therefore customer satisfaction,
increased market share, and sustainable growth.
59
60
Pillar 1: Financial Stewardships
Strategic Objective: To ensure a robust financial framework for a concrete financial base.
Strategy Activity Re- Target/Time frame (by Plan Year)
sponsi- Year 1 Year 2 Year 3 Year 4 Year 5
ble Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Cost Man- Implement activity based DFS 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%- 95%-
agement budgeting 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
Integration of distribution of DO 80% 81% 82% 83% 84% 85% 86% 87% 88% 89% 90% 91% 92% 93% 94% 95% 96% 97% 98% 99%
KEMSA EMMS & Program
items
Continuous Measurement of tar- >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90% >90%
gets disaggregated by segment of of of of of of of of of of of of of of of of of of of of
DCS target tar- target target target tar- tar- tar- target tar- target target tar- target tar- target tar- tar- tar- target
get get get get get get get get get get
Conduct Quarterly performance 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
review meetings
DCS
Continuous engagement with key Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con- Con-
stakeholders CEO tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu- tinu-
ous ous ous ous ous ous ous ous ous ous ous ous ous ous ous ous ous ous ous ous
Improve mar- Execute advertising and publicity 4 5 5 1 4 5 5 1 4 5 5 1 4 5 5 1 4 5 5 1
keting commu- campaigns
PRCM
nication
Redesign and regularly update
the website
PRCM
61
Media Engagements PRCM
62
Pillar 2: Customer Focus
Strategic Objective 2: Increase Market Share from 70% to 90%.
Strategic Objective 3: To have robust internal processes and systems that support the business.
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
63
64
Pillar 3: Internal Processes & Systems
Strategic Objective 3: To have robust internal processes and systems that support the business.
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Review of SOPs and Conduct Procurements PD &
adopt e-procurement through e-Procurement ICTM
platform
Review of SOPs
QAM/
HODs
Expand the wet chemis- Test 90% of the products QAM
try Lab and increase the procured by KEMSA
testing capacity
Implement the Laborato- Automate the Lab Processes QAM/
ry Information Manage- into LIMS system ICTM
ment System(LIMS)
Upgrade a testing QAM
Construct or refurbish a
Laboratory for health
testing Laboratory for
technologies to enhance
health technologies
their testing
Improve Capacity of Recruit and train additional DHRA/
Quality Assurance Quality Assurance staff QAM
Optimal material han- OD/WM
dling Acquire MHEs
OD/
Improve KEMSA storage Increase the available stor-
DHRA/
space capacity for HPTs age space capacity for HPTs
QAM
Strategic Objective 3: To have robust internal processes and systems that support the business.
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
65
66
Pillar 3: Internal Processes & Systems
Strategic Objective 3: To have robust internal processes and systems that support the business.
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Enhance staff mobility mar-
Tender for purchase / lease
when transacting KEM- DHRA ket
new pool fleet
SA business
Improve Staff welfare Acquire staff canteen
by provision of ame- Identify and implement
DHRA
nities and recreational staff canteen and recreation
activities activities
Establish employee assis- Initiate employees assis-
DHRA
tance programmes tance programmes
Provide clean water for Install and operationalize
DHRA
staff water treatment plant
Respon-
Strategy Activity
67
DCS
ufacturers
68
Pillar 4: Strategic Partnerships
Strategic Objective 4: Develop and strengthen strategic alliances and partnerships for improved health supply chain systems
Respon-
Strategy Activity
sible Year 1 Year 2 Year 3 Year 4 Year 5
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
69
70
Pillar 5: Leadership and Governance
Strategic Objective 5: To develop a dynamic, transparent and accountable governance structure
Strategy Activity Responsi- Target/Time frame (by Plan Year)
ble Year 1 Year 2 Year 3 Year 4 Year 5
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Review, implement and sensi- CSO
tize internal and
71
Annex 2: Enterprise Risk Management Matrix
72
(a) Financial Stewardship
Sources/Causes Score
Risk/ (Opportunity)
Strategy Likeli- Treatment Strategy/Action
Description Impact Overall
hood
Poor quantification 1. Proper and accurate data for forecasting
and quantification.
Expiries Introduction of new products with no 3 3 9
or low demand. 2. Consider Just-in-time acquisition of some
Increase in de- Products
mand for KEMSA Use of informed technical staff (both KEM-
Products Change in treatment regimen or
Obsolescence 3 1 3 SA and customers side) during product
technology
selection
Poor supplier performance Enforce contract management 2. Utilizing
Stock outs 3 3 9
Poor quantification supplier performance appraisal tool.
Getting threshold of the small orders based
Uneconomic Orders Lack of distribution costing model 2 3 6
on the distribution-costing model.
Increase in outstand- Lack of historical debt repayment Conducting market research on repayment
3 2 6
ing Debt information history of customers.
Venture into new
markets. Inability to fulfil Lack of historical consumption data Conducting market research before ventur-
1 2 2
needs of new markets on customers ing into new markets
Unscrupulous business men who Due diligence through Know Your Custom-
Fraudulent orders want to utilize organizational loop 3 1 3 er (KYC) procedures before engaging new
holes business partners/customers.
Reduction in donor Change of policy Have a pool of donors and constant lobby-
3 2 6
funding Growth in economy ing for new partners.
Establish a costing policy for pricing donor
Unviable partnerships Lack of costing policy 3 2 6
funded projects.
Political interference
Increase reve- Counter press statements and frequent doc-
Bad publicity Audit Reports 2 3 6
nue from supply umentary on KEMSA.
chain services Poor performance
The government Lack of funding from the exche-
not honoring their quer
Constant lobbying with treasury and
commitment with 3 2 6
MOH
development part- Lack of budgetary provision.
ners.
b) Customer Focus
Sources/Causes Score
Risk/ (Opportunity)
Strategy Likeli- Treatment Strategy/Action
Description Impact Overall
hood
73
Score
74
Risk/ (Opportunity) Sources/Causes
Strategy Likeli- Treatment Strategy/Action
Description Impact Overall
hood
Expiries Change of guidelines 3 2 6 Regular Post distribution Surveillance
Obsolescence Inaccurate forecasting 3 1 3 Regular Post Distribution surveillance
Inadequate funds Unpaid debts 3 2 6 Improve on debt collection mechanism
Increase the de-
mand for KEMSA Stock outs Poor Quantification
Health Products Non delivery by suppliers 3 3 9 Data driven forecasting & Quantification
& Technologies Inadequate Storage
space Over stocking 2 1 2 Proper planning
Increased Holding
cost Over stocking 2 1 2 Proper forecasting, demand planning
Loss of Business Change/unsupportive Laws/ 3 2 6 Continuous advocacy
Enhance commer- Inadequacy of funds Unpaid debts 2 2 4 debt management
cial performance Obsolescence Technological changes 3 1 3 Regular post marketing surveillance
Inadequacy of funds Lack of budgeting 3 2 6 Timely initiation of procurement.
Improve market-
Reputational damage. Negative publicity 3 2 6 Media management
ing communica-
tion Delayed dissemina-
Lengthy procurement process
tion of information 2 3 6 Proper procurement planning
Failure to attract the Sensitize leadership at the facilities on the
Personal Interest 2 2 4
right target group. need to train the right staff.
Improve custom- Attrition Dissatisfaction 2 2 4 Continuous on-job training
er relationship Inaccurate/Biased Knowledge management
management information during
Use of inaccurate tools/Methods 2 2 4 Recruitment of competent consultants to
customer satisfaction
surveys carry out customer satisfaction survey.
Strengthen the Inadequate funds Budget constraints 2 1 2 Adequate procurement planning
capacity of SSD Unpaid debts
75
Score
76
Risk/ (Opportunity) Sources/Causes
Strategy Likeli- Treatment Strategy/Action
Description Impact Overall
hood
Support KEM- Inability to disseminate correct KEM-
Enhance information privacy
SA management Negative publicity SA narrative.
systems and Gutter press Media training
3 2 6
processes through
Natural calamities Strengthen computer systems security.
automation and Loss of data
innovation Fire and Hacking Offsite data backup
d) Strategic Partnerships
Sources/Causes Score Treatment Strategy/Action
Risk/ (Opportunity)
Strategy Likeli-
Description Impact Overall
hood
Negative publicity Manage media content
Lack of transparency and account-
Compliance to partner requirements
ability
Develop and
sustain transfor- Failure to meet expectations Monitor and evaluate performance regularly
mational rela- Failure in collabora- Host country policies Adhere to partner guidelines and policies
3 1 3
tionships with tion by partners Non-compliance to partner policies
development
and guidelines
partners.
Legislations
Poor organizational performance
Poor organizational systems
Inadequate funds to Low internal revenues
Ensure availability of budgets and funds to
support collaboration Reduced government support 2 1 2
support strategic partner engagement
activities Changing spending priorities
Leverage on the
Lack of inclusivity in strategic deci-
strength of local Lack of Management Ensure internal collaboration in strategic
sion making 3 1 3
manufacturers /leadership support decision making
and industry Resistance to change
players. Lack of non-pharm testing mecha-
nisms
Low quality 3 2 6 Enforce quality requirements
Failure to adhere to regulatory re-
quirements
77
Natural and manmade disasters 3 2 6 Implementation of BCM programs
ERM ations
Score
78
Risk/ (Opportunity) Sources/Causes
Strategy Likeli- Treatment Strategy/Action
Description Impact Overall
hood
Strengthen
public opinion, Political interferences Have constant media engagements
attitude and Negative publicity Disgruntled staff 3 2 6 Implement social media campaigns
behavior of key Vested business interest Stakeholders’ engagement
stakeholders
Annex 3: Key Achievement Highlights per Department/Function
Best Ever
2018/2019 %age
Directorate / Unit of Mea- performance
Performance Indicator Target Re- Achieve- Comment
Department sure during the
vised ment rating
period
Mitigated Enterprise risks (Fully and Fully 50% 29% 58% Fair
Audit Percentage
Partially) Partially 50% 26% 52% Fair
Percentage Re-
98% 76% 78% Good
Customer Complaints Response and sponse 1 day
Customer Service
Resolution Cycle Times (Days) Percentage Reso-
90% 51% 57% Fair
lution 5 days
Order Turnaround Time (Hospitals Days 7.0 9.1 77% Good
Customer Service
& RHFs) Days 10.0 15.2 66% Fair
Order Fill Rate Customer Service Percentage 90% 78% 87% Good
Commercial Di-
Strategic partners (Cumulative) Number 12 11 92% Good
rector
79
80 Strategic Plan 2019 – 2024